HRP20110575T1 - Postupak pročišćavanja montelukasta i njegovih soli amina - Google Patents

Postupak pročišćavanja montelukasta i njegovih soli amina Download PDF

Info

Publication number
HRP20110575T1
HRP20110575T1 HR20110575T HRP20110575T HRP20110575T1 HR P20110575 T1 HRP20110575 T1 HR P20110575T1 HR 20110575 T HR20110575 T HR 20110575T HR P20110575 T HRP20110575 T HR P20110575T HR P20110575 T1 HRP20110575 T1 HR P20110575T1
Authority
HR
Croatia
Prior art keywords
montelukast
salt
purification process
process according
solvent
Prior art date
Application number
HR20110575T
Other languages
English (en)
Croatian (hr)
Inventor
Gasanz Guillen Yolanda
Monsalvatje Llagostera Montserrat
Talavera Escasany Pedro
Original Assignee
Esteve Quimica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Quimica filed Critical Esteve Quimica
Publication of HRP20110575T1 publication Critical patent/HRP20110575T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Quinoline Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR20110575T 2006-08-09 2007-08-07 Postupak pročišćavanja montelukasta i njegovih soli amina HRP20110575T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83685606P 2006-08-09 2006-08-09
EP06118690A EP1886998A1 (de) 2006-08-09 2006-08-09 Verfahren zur Reinigung von Montelukast und dessen Aminesalzen
PCT/EP2007/058180 WO2008017669A1 (en) 2006-08-09 2007-08-07 Purification process of montelukast and its amine salts

Publications (1)

Publication Number Publication Date
HRP20110575T1 true HRP20110575T1 (hr) 2011-09-30

Family

ID=37625598

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110575T HRP20110575T1 (hr) 2006-08-09 2007-08-07 Postupak pročišćavanja montelukasta i njegovih soli amina

Country Status (19)

Country Link
US (1) US8188285B2 (de)
EP (2) EP1886998A1 (de)
JP (1) JP5188501B2 (de)
KR (1) KR20090035696A (de)
CN (1) CN101501000B (de)
AT (1) ATE515498T1 (de)
AU (1) AU2007283615A1 (de)
CA (1) CA2657775A1 (de)
ES (1) ES2372414T3 (de)
HR (1) HRP20110575T1 (de)
IL (1) IL196303A (de)
MX (1) MX2009000524A (de)
NO (1) NO20091051L (de)
PL (1) PL2077996T3 (de)
PT (1) PT2077996E (de)
RU (1) RU2009108272A (de)
SI (1) SI2077996T1 (de)
WO (1) WO2008017669A1 (de)
ZA (1) ZA200900890B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7812168B2 (en) 2005-07-05 2010-10-12 Teva Pharmaceutical Industries Ltd. Purification of montelukast
KR101469015B1 (ko) * 2008-02-25 2014-12-05 주식회사 종근당 몬테루카스트의 제조방법 및 이에 사용되는 중간체
WO2009117381A2 (en) * 2008-03-17 2009-09-24 Dr. Reddy's Laboratories Ltd. Preparation of montelukast and its salts
KR101123292B1 (ko) 2008-09-26 2012-03-19 주식회사 엘지생명과학 몬테루카스트 나트륨염의 제조방법
WO2011121091A1 (en) 2010-03-31 2011-10-06 Krka, D.D., Novo Mesto Efficient synthesis for the preparation of montelukast and novel crystalline form of intermediates therein
KR100990046B1 (ko) * 2010-07-30 2010-10-26 동국제약 주식회사 신규한 몬테루카스트 4-할로 벤질아민염 및 이를 이용한 몬테루카스트 나트륨염의 제조방법
HUP1000425A2 (en) 2010-08-11 2012-03-28 Richter Gedeon Nyrt Process for the production of montelukast sodium
WO2012077133A1 (en) * 2010-12-07 2012-06-14 Ind-Swift Laboratories Limited Processes for preparation of montelukast sodium and purification of diol intermediate
CN102060762B (zh) * 2011-01-28 2013-05-29 海南美大制药有限公司 孟鲁司特化合物及其新制法
CN103570618A (zh) * 2013-09-30 2014-02-12 浙江车头制药股份有限公司 一种孟鲁司特钠盐的制备方法
CN105924392B (zh) * 2016-02-29 2018-03-02 山东新时代药业有限公司 一种孟鲁司特钠制备方法
CN105585524B (zh) * 2016-02-29 2018-03-02 山东新时代药业有限公司 一种由孟鲁司特酸制备孟鲁司特钠的方法
CN105646344B (zh) * 2016-02-29 2018-08-14 山东新时代药业有限公司 一种孟鲁司特的纯化方法
WO2019020580A1 (en) * 2017-07-24 2019-01-31 Interquim, S.A. PROCESS FOR PREPARING AND PURIFYING LIFITEGRAST ANTAGONIST OF LFA-1
IT201800006337A1 (it) * 2018-06-14 2019-12-14 Procedimento per la preparazione di lifitegrast
AU2019334202A1 (en) 2018-09-06 2021-03-25 Innopharmascreen, Inc. Methods and compositions for treatment of asthma or parkinson's disease

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8403224A (nl) * 1984-10-24 1986-05-16 Oce Andeno Bv Dioxafosforinanen, de bereiding ervan en de toepassing voor het splitsen van optisch actieve verbindingen.
HU222344B1 (hu) * 1990-10-12 2003-06-28 Merck Frosst Canada & Co. Eljárás telítetlen hidroxi-alkil-kinolinsavak, és ezeket tartalmazó gyógyszerkészítmények előállítására
TW448160B (en) 1993-12-28 2001-08-01 Merck & Co Inc Novel dicyclohexylamine salt and process for the preparation of leukotriene antagonists
CN1420113A (zh) 2001-11-16 2003-05-28 北京上地新世纪生物医药研究所 孟鲁司特钠的制备方法及其制备中间体
CN1171873C (zh) 2001-12-26 2004-10-20 北京上地新世纪生物医药研究所 一种孟鲁司特钠的制备方法及其制备中间体
US20050107612A1 (en) * 2002-12-30 2005-05-19 Dr. Reddy's Laboratories Limited Process for preparation of montelukast and its salts
AU2003253247A1 (en) * 2003-06-06 2005-01-04 Morepen Laboratories Limited An improved method for the preparation of montelukast acid and sodium salt thereof in amorphous form
JP2007508271A (ja) * 2003-10-10 2007-04-05 シントン・ベスローテン・フェンノートシャップ 固体状態のモンテルカスト
MXPA06008584A (es) * 2004-01-30 2007-04-16 Teva Pharma Polimorfos de acido libre de montelukast.
US7189853B2 (en) * 2004-04-15 2007-03-13 Dr. Reddy's Laboratories Limited Process for the preparation of [R-(E)-1-[[[1-[3-[2-[7-chloro-2-quinolinyl]ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid (Montelukast) and its pharmaceutically acceptable salts
MXPA06012220A (es) 2004-04-21 2007-07-18 Teva Pharma Procesos para preparar sodio de montelukast.
US7501517B2 (en) 2004-04-30 2009-03-10 Synthon Ip, Inc. Process for making montelukast and intermediates therefor
US7829716B2 (en) 2004-04-30 2010-11-09 Synthon Pharmaceuticals, Inc. Process for making montelukast and intermediates therefor
WO2006008751A2 (en) * 2004-07-19 2006-01-26 Matrix Laboratories Ltd Process for the preparation of montelukast and its salts
PL205637B1 (pl) * 2004-10-22 2010-05-31 Inst Farmaceutyczny Sposób wytwarzania kwasu (R,E)-(1-{1-{3-[2-(7-chlorochinolin-2-ylo)etenylo]fenylo}-3-[2-(1-hydroksy-1-metyloetylo)fenylo] propylosulfanylometylo}cyklopropylo)octowego i/lub jego farmaceutycznie dopuszczalnych soli
US7812168B2 (en) 2005-07-05 2010-10-12 Teva Pharmaceutical Industries Ltd. Purification of montelukast
US20100168432A1 (en) 2005-07-05 2010-07-01 Matrix Laboratories Ltd Process for the Preparation of Montelukast
KR20080033425A (ko) 2005-07-20 2008-04-16 닥터 레디스 래보러토리즈, 인코포레이티드 몬테루캐스트의 제조 공정
US8178680B2 (en) 2005-12-13 2012-05-15 Msn Laboratories Limited Process for the preparation of Montelukast and its pharmaceutically acceptable salts
CA2632954A1 (en) 2005-12-23 2007-06-28 Glade Organics Private Limited An improved process for the manufacture of montelukast sodium
IL181485A0 (en) 2006-02-21 2007-07-04 Chemagis Ltd Processes for preparing novel montelukast salts
WO2007096889A2 (en) 2006-02-27 2007-08-30 Chemagis Ltd. Process for preparing montelukast and salts thereof
WO2007107297A1 (en) 2006-03-17 2007-09-27 Synthon B.V. Montelukast amantadine salt
EP2004608B1 (de) 2006-04-12 2011-09-14 Glade Organics Private Limited Verbessertes verfahren zur herstellung von montelukast-natrium
US20090326232A1 (en) 2006-06-26 2009-12-31 Uttam Kumar Ray Process for the Preparation of Leukotriene Receptor Antagonist (Montelukast Sodium)
GB0614485D0 (en) 2006-07-21 2006-09-27 Pliva Istrazivanje I Razvoj D Process
EP2069307A4 (de) 2006-08-04 2010-03-03 Matrix Lab Ltd Verfahren zur herstellung von montelukast und salzen daraus

Also Published As

Publication number Publication date
ATE515498T1 (de) 2011-07-15
EP2077996B1 (de) 2011-07-06
US20090247759A1 (en) 2009-10-01
JP2010500325A (ja) 2010-01-07
IL196303A (en) 2014-03-31
PT2077996E (pt) 2011-09-13
EP2077996A1 (de) 2009-07-15
PL2077996T3 (pl) 2011-11-30
CN101501000B (zh) 2012-04-04
CA2657775A1 (en) 2008-02-14
NO20091051L (no) 2009-05-05
KR20090035696A (ko) 2009-04-10
IL196303A0 (en) 2009-09-22
RU2009108272A (ru) 2010-09-20
SI2077996T1 (sl) 2011-10-28
US8188285B2 (en) 2012-05-29
JP5188501B2 (ja) 2013-04-24
AU2007283615A1 (en) 2008-02-14
CN101501000A (zh) 2009-08-05
ZA200900890B (en) 2010-04-28
MX2009000524A (es) 2009-01-27
EP1886998A1 (de) 2008-02-13
ES2372414T3 (es) 2012-01-19
WO2008017669A1 (en) 2008-02-14

Similar Documents

Publication Publication Date Title
RU2009108272A (ru) Способ очистки монтелукаста и его аминосолей
TW200508300A (en) Composition and method for removing copper-compatible resist
WO2007053672A3 (en) Solvent compositions comprising unsaturated fluorinated hydrocarbons
UY30475A1 (es) Procedimientos para fabricar bromuro de 3(r)-(2-hidroxi-2,2-dietien-2-ilaxetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo[2.2.2]octano.
DE602007013242D1 (de) Herstellung von essigsäure
ATE342951T1 (de) Verfahren zum rückgewinnen von öl
HRP20110322T1 (hr) Postupak za pročišćavanje montelukasta
ATE540926T1 (de) Verbessertes verfahren zur herstellung von montelukastsäure natriumsalz in amorpher form
TW200745785A (en) Recycling method for resist stripper scrapped and recycling device for the same
DE602005011010D1 (de) Abtrennung von propylenoxid aus einer propylenoxid und methanol enthaltenden mischung
WO2010129809A3 (en) Glycerin purification
DE502007002282D1 (de) Verfahren zur aufarbeitung von lösungsmittel enthaltenden hydrierausträgen
CN103232369A (zh) 一种芴甲氧羰酰谷氨酸-5-叔丁酯的制备方法
RU2014112957A (ru) Способ выделения ингенола
CN103951604B (zh) 一种吲哚分离与提纯的方法
CN107686852A (zh) 一种莫西沙星中间体化合物的制备方法
CN102199442B (zh) 胺类质子型离子液体萃取剂用于油品脱硫及萃取剂回收方法
Vallejo et al. N-Demethyl-sauroxine, a novel Lycodine Group alkaloid from Huperzia saururus
IL182846A (en) Membrane for the separation of material mixtures and methods for the production thereof
CN103396827B (zh) 煤液化油中碱性氮化合物的分离方法
WO2019029598A1 (zh) 一种制备左乙拉西坦的方法
ATE404549T1 (de) Neue pharmakologisch aktive dauerpheromonverbindung zur steuerung von alterung und stress sowie verfahren zu deren isolierung und kennzeichnung
DE102004037002B4 (de) Verfahren zur Herstellung von Dimethylaminoarglabin-Hydrochlorid
CN104710312B (zh) 一种从菊芋叶中分离二咖啡酰基奎尼酸的方法
JP2021000603A5 (de)